EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NSFC-funded Chinese materia medica research (2015–2024): achievements output, research characteristics, and evolution

Hu Jin, Wang Can, Song Wei, Bai Hua, Wu Qunli

Frontiers in Pharmacology · 04.08.2026 · 17

DOI: 10.3389/fphar.2026.1908693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 04.08.2026. Verfasst von Hu Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Scientific Research, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, …. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To systematically analyze the project completion status and research characteristics in the field of Chinese Materia Medica (CMM, discipline code H32) funded by the National Natural Science Foundation of China (NSFC), thereby providing a basis for optimizing the allocation of scientific research resources and adjusting funding strategies.

Methods

Based on the NSFC big database system, a retrospective analysis was conducted to descriptively analyze the research output, potential translational capacity, and research characteristics of completed projects in the CMM field funded by NSFC from 2015 to 2024.

Results

From 2015 to 2024, a total of 4,574 projects in the CMM field were completed, with a compound annual growth rate (CAGR) of 3.0%. The cumulative total funding was 1.86 billion RMB, with an average of 410 KRMB per project. The average research output was 6.6 items per project, and the potential patent conversion ratio was 61%. For the first time, the 19 sub-directions within the CMM field were categorized into four echelons: double-high advantage, high-output low-conversion, low-output high-conversion, and Low-Output Low-Conversion areas. Key advantage areas included CMM pharmacodynamic substances, CMM resources, and ethnic pharmacology. Disease research primarily focused on cardiovascular and cerebrovascular diseases, tumors, metabolic diseases, and neurological disorders. Technical methodologies rapidly evolved from traditional chemical analysis to multi-omics and systems biology, while research mechanisms expanded towards multi-dimensional regulatory networks.

Conclusion

NSFC funding for the CMM field has been consistently stable. The discipline demonstrates an overall trajectory characterized by deepening basic research, rapid iteration of technical methods, increasing diversification of research directions, and steadily improving translational potential. These findings provide data support and decision-making references for optimizing NSFC funding strategies in the CMM field.

Schlagwörter

Stichwörter der Autor:innen

Chinese materia medicadiscipline developmentnational natural science foundation of China (NSFC)research characteristicsresearch translationscientific research output

Autor:innen und Institutionen

  • Office of Scientific Research, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Zitieren

APA

Jin, H., Can, W., Wei, S., Hua, B., & Qunli, W. (2026). NSFC-funded Chinese materia medica research (2015–2024): achievements output, research characteristics, and evolution. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1908693

Vancouver

Jin H, Can W, Wei S, Hua B, Qunli W. NSFC-funded Chinese materia medica research (2015–2024): achievements output, research characteristics, and evolution. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1908693

BibTeX
@article{Jin2026,
  author = {Jin, Hu and Can, Wang and Wei, Song and Hua, Bai and Qunli, Wu},
  title = {NSFC-funded Chinese materia medica research (2015–2024): achievements output, research characteristics, and evolution},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1908693}
}
Kostenlos starten →